CJ Wolf
April 2022 has brought more items to the OIG Work Plan. Let’s take a closer look at them.
CJ Wolf
In this episode of Compliance Conversations, our host CJ Wolf, MD., sits down with Amy Brown
CJ Wolf
The OIG has stated that entities “should regularly review the implementation and execution
CJ Wolf
I recently sat down with my fellow compliance professional and friend, Brian Burton,
CJ Wolf
“Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc., and Apotex Corporation
CJ Wolf
HHS OCR tracks and publicly reports the top five issues in their investigated cases closed with corrective action.
CJ Wolf
Hello folks! Many new items were added to the OIG’s Work Plan in March.
CJ Wolf
Gathering together again in person, at last! Finally, the healthcare compliance community met face-to-face again
